tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market

Takeda Pharmaceutical Co (TKPHF) Income Statement

Compare
35 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q2 2025), Takeda Pharmaceutical Co's total revenue was ¥1.11T, a decrease of -5.38% from the same quarter last year. In Q2, Takeda Pharmaceutical Co's net income was ¥-11.80B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit
¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T¥ 1.80T
Operating Expenses
¥ 1.83T¥ 1.79T¥ 1.64T¥ 1.43T¥ 1.35T
Depreciation and Amortization
¥ 761.40B¥ 728.00B¥ 664.40B¥ 583.15B¥ 559.67B
EBITDA
¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T¥ 1.07T
Operating Income
¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B¥ 447.61B
Other Income/Expenses
¥ -452.46B¥ -478.63B¥ -283.20B¥ -307.93B¥ -81.38B
Pretax Income
¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B¥ 366.24B
Net Income
¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Per Share Metrics
Basic EPS
¥ 68.36¥ 92.09¥ 204.29¥ 147.14¥ 240.72
Diluted EPS
¥ 67.23¥ 91.16¥ 201.94¥ 145.87¥ 238.96
Weighted Average Shares Outstanding
1.58B 1.56B 1.55B 1.56B 1.56B
Weighted Average Shares Outstanding (Diluted)
1.61B 1.58B 1.57B 1.58B 1.57B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History